Brief: Silo Pharma Filed Percent Patent Application Related To Methods Of Treating Alzheimer's Disease Using Prucalopride And Ketamine
31/08/2023 12:40
Aug 31 (Reuters) - Silo Pharma Inc SILO.O :
* SILO PHARMA - ON AUG 25, FILED PERCENT PATENT APPLICATION
RELATED TO METHODS OF TREATING ALZHEIMER'S DISEASE USING
PRUCALOPRIDE AND KETAMINE
Further company coverage: SILO.O
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement